**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 389-40-2 |2,3,4,5,6-Pentafluoroanisole | 97+% | 206-866-8 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: None Listed.
Risk Phrases: 10
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Flammable.The toxicological properties of this material have not
been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation. May cause chemical conjunctivitis and
corneal damage.
Skin:
May cause irritation and dermatitis. May cause cyanosis of the
extremities.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea. May cause cardiac disturbances. The toxicological
properties of this substance have not been fully investigated.
Ingestion of large amounts may cause CNS depression.
Inhalation:
May cause respiratory tract irritation. The toxicological properties
of this substance have not been fully investigated. Aspiration may
lead to pulmonary edema. Vapors may cause dizziness or suffocation.
May cause cardiac abnormalities. Inhalation at high concentrations
may cause CNS depression and asphixiation. May cause burning
sensation in the chest.
Chronic:
Effects may be delayed. Chronic exposure to fluoride compounds may
cause systemic toxicity.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid immediately. Do NOT induce vomiting. If conscious and alert,
rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh
air immediately. If breathing is difficult, give oxygen. Do NOT use
mouth-to-mouth resuscitation. If breathing has ceased apply
artificial respiration using oxygen and a suitable mechanical device
such as a bag and a mask.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. Vapors may form an explosive mixture with air.
Vapors can travel to a source of ignition and flash back. During a
fire, irritating and highly toxic gases may be generated by thermal
decomposition or combustion. Will burn if involved in a fire. Use
water spray to keep fire-exposed containers cool. Containers may
explode in the heat of a fire. Flammable liquid and vapor. Vapors
may be heavier than air. They can spread along the ground and
collect in low or confined areas. Runoff from fire control or
dilution water may cause pollution.
Extinguishing Media:
For small fires, use dry chemical, carbon dioxide, water spray or
alcohol-resistant foam. For large fires, use water spray, fog, or
alcohol-resistant foam. Use water spray to cool fire-exposed
containers. Water may be ineffective. Do NOT use straight streams of
water.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth),
then place in suitable container. Avoid runoff into storm sewers and
ditches which lead to waterways. Clean up spills immediately,
observing precautions in the Protective Equipment section. Remove all
sources of ignition. Use a spark-proof tool. Provide ventilation. A
vapor suppressing foam may be used to reduce vapors.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Use with adequate ventilation.
Ground and bond containers when transferring material. Use
spark-proof tools and explosion proof equipment. Avoid contact with
eyes, skin, and clothing. Empty containers retain product residue,
(liquid and/or vapor), and can be dangerous. Keep container tightly
closed. Keep away from heat, sparks and flame. Avoid ingestion and
inhalation. Do not pressurize, cut, weld, braze, solder, drill,
grind, or expose empty containers to heat, sparks or open flames.
Storage:
Keep away from sources of ignition. Store in a tightly closed
container. Flammables-area.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 389-40-2:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to minimize
contact with skin.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Liquid
Color: clear, colorless
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 138 - 139 deg C @ 760.00mmHg
Freezing/Melting Point: Not available.
Autoignition Temperature: Not applicable.
Flash Point: 32 deg C ( 89.60 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density: 1.3980g/cm3
Molecular Formula: C7H3F5O
Molecular Weight: 198.09
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, ignition sources, excess heat, strong
oxidants.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, irritating and toxic fumes and gases, carbon
dioxide.
Hazardous Polymerization: Has not been reported
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 389-40-2 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
2,3,4,5,6-Pentafluoroanisole -
Not listed by ACGIH, IARC, or NTP.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: FLAMMABLE LIQUID, N.O.S.*
Hazard Class: 3
UN Number: 1993
Packing Group: II
IMO
Shipping Name: FLAMMABLE LIQUID, N.O.S.
Hazard Class: 3.2
UN Number: 1993
Packing Group: II
RID/ADR
Shipping Name: FLAMMABLE LIQUID, N.O.S.
Hazard Class: 3
UN Number: 1993
Packing group: II
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
R 10 Flammable.
Safety Phrases:
S 9 Keep container in a well-ventilated place.
S 16 Keep away from sources of ignition - No
smoking.
S 33 Take precautionary measures against static
discharges.
WGK (Water Danger/Protection)
CAS# 389-40-2: No information available.
Canada
CAS# 389-40-2 is listed on Canada's NDSL List.
CAS# 389-40-2 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 389-40-2 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 9/02/1997 Revision #5 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Monomethyl monopotassiummalonate, 98%
| 38330-80-2 |
|
4-Bromomandelic Acid, 96% (HPLC)
| 6940-50-7 |
|
Stigmasterol, 95%
| 83-48-7 |
|
2-Chloro-6-Nitrotoluene, 99%
| 83-42-1 |
|
[Tris(trimethylsilyl)]arsenide, 98%
| 17729-30-5 |
|
1-Ethylquinaldinium Iodide, 97% (titr.)
| 606-55-3 |
|
L-Aspartyl-L-Phenylalanine Methyl Ester, 98%
| 22839-47-0 |
|
Primaquine diphosphate, 99+%
| 63-45-6 |
|
Ethyl 5-Hydroxy-2-Methylindole-3- Carboxylate
| 7598-91-6 |
|
(R)-(-)-1-Amino-2-Propanol, 98+%
| 2799-16-8 |
|
N-Methylthiourea, 97%
| 598-52-7 |
|
2,3,4,5,6-Pentafluoroanisole, 97+%
| 389-40-2 |
|
Cyclohexene Oxide, 98%
| 286-20-4 |
|
5-beta-Pregnane-3-alpha,20-alpha-diol, 99%
| 80-92-2 |
|
Cyclooctene Oxide, 99%
| 286-62-4 |
|
2-(4-Methoxyphenyl)-4,6-Diphenylpyrylium Tetrafluoroborate
| 2907-13-3 |
|
Sodium Hexafluoroantimonate, 98% (Titr.)
| 16925-25-0 |
|
Ethylene/Acrylic Acid Copolymer
| 9010-77-9 |
|
4-Fluoro-2-Nitrotoluene, 98%
| 446-10-6 |
|
N-Carbethoxy-4-Piperidone, 97+%
| 29976-53-2 |
|
3-Methylhippuric acid,98+%
| 27115-49-7 |
|
Amberlite cg-400 ion-exchange resin
| 37247-87-3 |
|
3-Nitrotoluene, 99%
| 99-08-1 |
|
1,3-Diphenylguanidine, 99% (uv-vis)
| 102-06-7 |
|
2-Bromo-4-Methylaniline, 98%
| 583-68-6 |
|
2,2'-Bithiophene
| 492-97-7 |
|
5,6-Dimethylbenzimidazole, 99+%
| 582-60-5 |
|
4-Butoxyaniline, 99% (titr.)
| 4344-55-2 |
|
Alpha-Cyano-O-Tolunitrile, Tech.
| 3759-28-2 |
|
DL-Laudanosoline Hydrobromide Trihydrate, 98%
| 485-33-6 |
|
4-Chloro-6-Nitro-Meta-Cresol, 99%
| 7147-89-9 |
|
2-Butanone oxime, 99%
| 96-29-7 |
|
Hexachloropropene, 96%
| 1888-71-7 |
|
Isopropyl Chloroacetate, 99%
| 105-48-6 |
|
3-Methylpentane, 99+%
| 96-14-0 |
|
1,4-Cyclohexanedicarboxylic Acid, 96% (Titr.)
| 1076-97-7 |
|
Azoxybenzene, 97%
| 495-48-7 |
|
l-(+)-Lactic acid, lithium salt
| 27848-80-2 |
|
4-Hexylresorcinol, 99%
| 136-77-6 |
|
Tantalum (V) Chloride, 99.9%
| 7721-01-9 |
|
2,4,5-Trimethylthiazole, 99%
| 13623-11-5 |
|
Cycloheptane, 99%
| 291-64-5 |
|
Phenylglyoxal monohydrate, 97%
| 1074-12-0 |
|
Ethyl Carbazate, 97%
| 4114-31-2 |
|
bis(Methylthio)methane, 99+%
| 1618-26-4 |
|
1-Bromo-4-Tert-Butylbenzene, 97+%
| 3972-65-4 |
|
(S)-(+)-2-Amino-2-methylbutanoic acid monohydrate, 99+% (>99% e.e.)
| 0-00-0 |
|
2-Furonitrile, 99%
| 617-90-3 |
|
l-Adrenaline, 97% (titr.)
| 51-43-4 |
|
4-(3-Methyl-5-oxo-2-pyrazolin-1-yl)benzoic acid, 98+%
| 60875-16-3 |
|
|